Population pharmacokinetics of riociguat and its metabolite in patients with chronic thromboembolic pulmonary hypertension from routine clinical practice

Pharmacokinetic data for riociguat in patients with chronic thromboembolic pulmonary hypertension (CTEPH) have previously been reported from randomized clinical trials, which may not fully reflect the population encountered in routine practice. The aim of the current study was to characterize the ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Michaličková, Danica, Jansa, Pavel, Bursová, Miroslava, Hložek, Tomáš, Čabala, Radomír, Hartinger, Jan Miroslav, Ambrož, David, Aschermann, Michael, Lindner, Jaroslav, Linhart, Aleš, Slanař, Ondřej, Krekels, Elke H.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011339/
https://www.ncbi.nlm.nih.gov/pubmed/32095231
http://dx.doi.org/10.1177/2045894019898031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011339/
https://www.ncbi.nlm.nih.gov/pubmed/32095231
http://dx.doi.org/10.1177/2045894019898031

Ejemplares similares